Origin Materials will validate the FDCA production process from Eastman in Sarnia
After the last post
about the advancements of VTT on bioplastics field (muconic acid and furan
derivatives from aldaric acids), I bring another recent movement with regard to
2,5-furandicarboxylic
acid (FDCA). Late last month, Eastman
Chemical Company and Origin
Materials (formerly known as Micromidas) entered into a non-exclusive agreement
for Eastman to license its proprietary FDCA and FDCA derivatives production
technology from renewable resources to Origin Materials (press
release, 25/09/2017).
Eastman has developed a process for
economically competitive conversion of 5-hydroxymethylfurfural (5-HMF) and its
derivatives to crude FDCA, polymer grade FDCA and polymer grade dimethylfuran-2,5-dicarboxylate
(DMF). The acquisition of this technology will enable Origin Materials to
produce FDCA monomer, which can then be used by its customers to manufacture polyethylene
furanoate (PEF) bottles and films.
Eastman technology:
Process
|
Oxidation
of 5-HMF in the presence of oxygen, a saturated organic acid solvent and a
catalyst system to produce FDCA.
Patent: Oxidation process
to produce a crude and/or purified carboxylic acid product (US20150011783A1).
|
Starting
point
|
5-HMF,
5-HMF esters, 5-HMF ethers and 5-alkyl furfurals.
|
Oxidant
agent
|
O2.
|
Key
intermediate
|
5-formyl
furan-2-carboxyic acid (FFCA).
|
Solvent
|
Aqueous
acetic acid solution.
|
Catalyst
system
|
Co/Mn/Br.
|
Origin Materials is also working to develop and
launch at commercial scale polyethylene terephthalate (PET) plastic bottle made
from 100% sustainable and renewable resources (see post
about the formation of the NaturALL Bottle Alliance with Danone and Nestlé
Waters in March of this year).
In order to demonstrate both process technologies,
Origin Materials has purchased an oxidation pilot plant from Eastman. The facility
for biobased terephthalic acid (bio-PTA) and FDCA production will be located at
the Western Sarnia-Lambton Research Park (press
release, 26/09/2017).
Figure 1. Commercialization Centre at Western
Sarnia-Lambton Research Park (extracted from the web page or the park). The project
to relocate and validate the bio-PTA and FDCA production pilot plant is being
supported by BIC through its COMM SCI initiative.
The whole project will include the relocation,
commissioning and process validation of the pilot plant. This 6 M$ project is
being supported by Bioindustrial Innovation
Canada (BIC) through its COMM SCI (Centre for Commercialization of
Sustainable Chemistry Innovation) initiative with its partners Lambton College
and the Western Sarnia-Lambton Research Park. BIC will provide advice, services
and financial support for the removal of technical and market application barriers
to commercialization of bio-PTA and FDCA to enable commercial production of bio-PET
and PEF.